Cannabidiol (CBD)


Rabin Medical Center Conducts Clinical Trial Investigating Steroid-CBD Treatment on Hospitalized COVID-19 Patients

Rabin Medical Center’s Golda Hasharon Campus in Petah Tikva commences a small-scale clinical trial to investigate the effects of a steroid-Cannabidiol (CBD) treatment on hospitalized patients infected with SARS-CoV-2. Sponsored by the drug’s maker, Stero Biotechs, the...

Pin It on Pinterest